CrushSCI.com
116.8Average days
107Median days
41Fastest days
237Longest days
5272025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

71 days

Hypoxia‐inducible factor 2α inhibition in renal cell carcinoma: From von Hippel–Lindau biology to targeted therapeutics

Authors
Yu‐Wei Chen; Fumika Sano; Rana R. McKayShow moreShow less
Affiliations
1. Division of Medical Oncology University of California, San Diego Moores Cancer Center San Diego California USA; 2. University of California, San Diego School of Medicine San Diego California USAShow moreShow less
Source PDF DOI Publisher page
111 days

Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies

Authors
Cuipeng Qiu; Claus Høgdall; Hailing Yang; Wei‐Lei Yang; Tim S. Poulsen; Karen S. Anderson; Zhen Lu; Robert C. Bast; Estrid HøgdallShow moreShow less
Affiliations
1. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas USA; 2. Department of Gynecology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark; 3. Molecular Unit Department of Pathology Herlev Hospital University of Copenhagen Herlev Denmark; 4. Biodesign Institute Arizona State University Tempe Arizona USAShow moreShow less
Source PDF DOI Publisher page
225 days

Integration of individual‐level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer

Authors
Wonyoung Jung; Gary Hettinger; Vivek Narayan; Lin Mei; Samuel Takvorian; Yehoda M. Martei; Amy Clark; Anran Huang; Kellie Mcdermott; Amanda M. Smith; Congying Xia; Kyunga Ko; Javier Sierra Pagan; Daniel Koropeckyj‐Cox; Kelly Getz; Carmen E. Guerra; Oluwadamilola M. Fayanju; Sanchit Kumar; Kirsten M. M. Beyer; Tiffany Powell‐Wiley; Clyde Yancy; Yong‐Moon Mark Park; Bonnie KyShow moreShow less
Affiliations
1. Division of Cardiology Department of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 2. Thalheimer Center for Cardio‐Oncology Abramson Cancer Center Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 3. Department of Population Health New York University Grossman School of Medicine New York New York USA; 4. Division of Hematology and Oncology Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 5. Department of Internal Medicine Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA; 6. Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 7. Division of General Internal Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 8. Department of Surgery Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; 9. Institute for Health and Humanity Medical College of Wisconsin Milwaukee Wisconsin USA; 10. Social Determinants of Obesity and Cardiovascular Risk Laboratory Cardiovascular Branch Division of Intramural Research National Heart, Lung, and Blood Institute National Institutes of Health Bethesda Maryland USA; 11. Intramural Research Program National Institute on Minority Health and Health Disparities National Institutes of Health Bethesda Maryland USA; 12. Department of Internal Medicine Division of Cardiology Feinberg School of Medicine Northwestern University Chicago Illinois USA; 13. Department of Epidemiology Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences Little Rock Arkansas USA; 14. Cancer Prevention and Population Sciences Research Program Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock Arkansas USAShow moreShow less
Source PDF DOI Publisher page
56 days

Biomarker use in the prostate cancer screening pathway: Maps of the evidence

Authors
Rita L. Shiau; Jessica C. Griffin; Clarissa A. B. Troutman; Rose Relevo; Karli K. KondoShow moreShow less
Affiliations
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USAShow moreShow less
Source PDF DOI Publisher page
87 days

Prostate‐specific antigen‐based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline

Authors
Jessica C. Griffin; Rita L. Shiau; Clarissa A. B. Troutman; Alanna Welsh; Emily Edwards; Ibironke A. Ajayi; Rose Relevo; Karli K. KondoShow moreShow less
Affiliations
1. Center for Early Cancer Detection American Cancer Society Atlanta Georgia USA; 2. Research Integrity Oregon Health & Science University Portland Oregon USAShow moreShow less
Source PDF DOI Publisher page
127 days

Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients

Authors
Monica Sarker; Zhengyi Deng; Eric C. Kauffman; Li Tang; Marilyn L. Kwan; Marvin E. Langston; Sumati Gupta; G. Daniel Grass; Eric A. Singer; Yousef Zakharia; Paul V. Viscuse; Laura Graham; Saum Ghodoussipour; Bodour Salhia; Sean Q. Kern; Adanma Ayanambakkam; Zin Myint; Jennifer King; Seyi Oderinde; Michelle L. Churchman; Robert J. Rounbehler; Ken BataiShow moreShow less
Affiliations
1. Department of Cancer Prevention and Control Roswell Park Comprehensive Cancer Center Buffalo New York USA; 2. Department of Urology Stanford University School of Medicine Stanford California USA; 3. Department of Epidemiology Stanford University Palo Alto California USA; 4. Department of Urology Roswell Park Comprehensive Cancer Center Buffalo New York USA; 5. Division of Research Kaiser Permanente Northern California Pleasanton California USA; 6. Huntsman Cancer Institute Salt Lake City Utah USA; 7. H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA; 8. Department of Urology Ohio State University Columbus Ohio USA; 9. University of Iowa Holden Comprehensive Cancer Center Iowa City Iowa USA; 10. Division of Hematology/Oncology University of Virginia Comprehensive Cancer Center Charlottesville Virginia USA; 11. University of Colorado Anschutz Medical Campus Aurora Colorado USA; 12. Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA; 13. Norris Comprehensive Cancer Center and Keck School of Medicine of the University of Southern California Los Angeles California USA; 14. Murtha Cancer Center Uniformed Services University of the Health Sciences Bethesda Maryland USA; 15. Stephenson Cancer Center University of Oklahoma Oklahoma City Oklahoma USA; 16. Markey Cancer Center University of Kentucky Lexington Kentucky USA; 17. Indiana University Simon Comprehensive Cancer Center Indianapolis Indiana USA; 18. Aster Insights Tampa Florida USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CANCER take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for CANCER. The fastest paper went from submission to acceptance in 41 days (GPRC5D‐targeting bispecific and trispecific antibodies in multiple myeloma: Current evidence and emerging strategies, received 2026-06-16, accepted 2026-07-27); the slowest took 237 days. The average is 116.8 days and the median is 107 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.